Farther Finance Advisors »

Summit Therapeutics shares owned by Farther Finance Advisors

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Farther Finance Advisors from 13F filings

Historical chart of Farther Finance Advisors investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Farther Finance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Farther Finance Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.1M 55k 20.66

More positions owned by Farther Finance Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Vanguard S&p 500 Etf Etf (VOO)
Apple Stock (AAPL)
Nvidia Corporation Stock (NVDA)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Microsoft Corp Stock (MSFT)
Dimensional International Value Etf Etf (DFIV)
Ishares 0-3 Month Treasury Bond Etf Etf (SGOV)
Oreilly Automotive Stock (ORLY)
Schwab U.s. Large-cap Etf Etf (SCHX)
Ishares Core Total Usd Bond Market Etf Etf (IUSB)
Vanguard Short-term Corporate Bond Etf Etf (VCSH)
Amazon Stock (AMZN)
Invesco Qqq Trust Series I Etf (QQQ)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)

View all positions for Farther Finance Advisors

Top funds holding Summit Therapeutics

Baker Bros. Advisors
Vanguard Group
FMR
BlackRock
State Street Corporation
Geode Capital Management
Susquehanna International
Pictet Asset Management Holding SA
Citadel Advisors
UBS Group
Apeiron Capital
Nomura Holdings
Standard Life Aberdeen
Squarepoint Ops
Sofinnova Ventures

View all funds holding Summit Therapeutics